HIGHLIGHTS
- who: Anna Koperska and collaborators from the Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznan University of Medical Sciences, Szamarzewskiego, Poznan, Poland have published the research work: Berberine in Non-Alcoholic Fatty Liver Diseaseu2014A Review, in the Journal: Nutrients 2022, 14, 3459. of /2022/
- what: BBR appears to be a promising therapeutic agent for NASH as it targets multiple pathways.
- future: [39].Because Because MAFLD conception is gaining more attenthere is a need to provide studies assessing BBRBBR use use andand efficacy in this specific group of tion there is . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.